Vandazole

...
Views
Read Time
...
views
Read Time

Drug Overview

Vandazole is a highly effective medication utilized within the Gynecology drug category. It belongs to the Vaginal Antibiotic drug class and is specifically formulated to treat imbalances in the vaginal microbiome. This medication serves as a Targeted Therapy to eliminate harmful bacteria while helping to restore a healthy internal environment.

Vandazole is a colorless-to-straw-colored gel that is applied locally. Because it is applied directly to the site of infection, it allows for high concentrations of the active ingredient where it is needed most, often resulting in fewer whole-body side effects compared to oral antibiotics.

  • Generic Name: Metronidazole (0.75%)
  • US Brand Names: Vandazole, Metrogel-Vaginal
  • Route of Administration: Vaginal (Intravaginal)
  • FDA Approval Status: FDA-Approved

What Is It and How Does It Work? (Mechanism of Action)

Vandazole
Vandazole 2

Vandazole contains Metronidazole, a nitroimidazole that is a targeted therapy with potent antibacterial and antiprotozoal properties. To understand how it works at the molecular level, one must look at how it interacts with the metabolism of anaerobic bacteria.

Metronidazole acts as a “prodrug,” meaning it is inactive until it enters the target cell. Once inside the anaerobic microorganism, the nitro group of the Metronidazole molecule is reduced (chemically changed) by intracellular transport proteins, such as ferredoxin. This reduction process occurs only in anaerobic environments, which is why the drug specifically targets harmful bacteria without significantly harming the “good” aerobic bacteria (like Lactobacilli) that protect the vagina.

This chemical reduction creates highly reactive intermediate compounds (short-lived free radicals). These radicals directly attack the bacterial DNA, causing strand breakage and destabilizing the helical structure of the genetic material. By inducing DNA strand inhibition and preventing nucleic acid synthesis, the medication causes the rapid death of the bacteria. Unlike a Hormone Modulator, Vandazole does not influence the hypothalamic-pituitary-ovarian (HPO) axis; instead, it focuses entirely on the biochemical destruction of pathogens.

FDA-Approved Clinical Indications

Vandazole is primarily utilized to address common yet uncomfortable infections that affect women’s health and well-being.

  • Primary Gynecological/Obstetric Indications
    • Bacterial Vaginosis (BV): Specifically indicated for the treatment of BV (formerly referred to as Haemophilus vaginitis, Gardnerella vaginitis, or nonspecific vaginitis) in non-pregnant women.
  • Off-Label / Endocrinological Indications
    • Trichomoniasis: While oral Metronidazole is the standard treatment, the vaginal gel is occasionally used as a secondary Targeted Therapy for symptom relief in resistant cases.
    • Prophylaxis in Gynecological Surgery: Used off-label in some clinical settings to reduce the risk of post-operative infection following procedures like a hysterectomy.
    • Pelvic Inflammatory Disease (PID): Used as part of a multi-drug regimen to cover anaerobic organisms in the lower genital tract.

Dosage and Administration Protocols

Vandazole is supplied with specially designed applicators to ensure the correct dose is delivered to the upper vagina. The treatment is typically administered once daily for a short duration.

ParametersStandard Protocol
Dose per Application5 grams of gel (one full applicator)
Active Ingredient Amount37.5 mg of Metronidazole
FrequencyOnce daily
Duration of Treatment5 consecutive days
Best Time of DayAt bedtime (to maximize tissue contact time)

Special Populations:

  • Renal/Hepatic Insufficiency: Because systemic absorption of the vaginal gel is significantly lower than oral forms, dose adjustments are generally not required for mild to moderate impairment. However, clinicians should exercise caution in patients with severe hepatic failure.
  • Pediatric Use: Safety and effectiveness have not been established in residents who have not yet reached menarche (their first period).

Clinical Efficacy and Research Results

Clinical studies conducted and reviewed between 2020 and 2026 continue to support Vandazole as a gold-standard treatment for Bacterial Vaginosis.

  • Clinical Cure Rates: In multi-center clinical trials, women using the 0.75% Metronidazole vaginal gel showed clinical cure rates ranging from 70% to 80% at follow-up examinations (2 to 4 weeks post-treatment).
  • Resolution of Amsel Criteria: Research indicates that the majority of patients show a significant reduction in the standard “Amsel Criteria” used to diagnose BV. This includes a return to a normal vaginal pH (less than 4.5) and the total disappearance of “clue cells” on microscopic examination.
  • Symptom Improvement: Numerical data suggests that the “Whiff Test” (the presence of a fishy odor) becomes negative in approximately 90% of patients within 48 to 72 hours of the first application.

Safety Profile and Side Effects

Vandazole is generally well-tolerated because the medication acts locally, but patients should be aware of possible reactions.

Black Box Warning: There is no “Black Box Warning” for the vaginal formulation of Metronidazole. However, the oral form carries a warning regarding carcinogenicity in animal studies; as a precaution, Vandazole should only be used for its indicated purpose.

Common Side Effects (>10%)

  • Vaginal candidiasis (yeast infection) due to the shift in bacterial flora.
  • Vaginal pruritus (itching) or irritation.
  • Mild abdominal cramping.
  • A metallic taste in the mouth (though rare with vaginal use).

Serious Adverse Events

  • Convulsive Seizures and Peripheral Neuropathy: Extremely rare with vaginal application, but reported with systemic Metronidazole.
  • Disulfiram-like Reaction: If alcohol is consumed, patients may experience severe nausea, vomiting, and flushing.
  • Severe Leukopenia: A rare decrease in white blood cell counts.

Management Strategies

If a secondary yeast infection occurs, an “add-back” antifungal treatment (such as a fluconazole pill or cream) may be required. If severe neurological symptoms like numbness or tingling occur, the medication must be discontinued immediately.

Research Areas

Current clinical trials in women’s health are investigating the use of bio-adhesive gels to extend the release of Metronidazole, potentially reducing treatment from five days to a single dose. Additionally, there is significant interest in the “Vaginal Microbiome Transplant” and how antibiotics like Vandazole can be used to “clear the field” before introducing healthy donor bacteria to prevent the high recurrence rates of BV. Moreover, research is exploring how clearing chronic inflammation via Targeted Therapy can improve the success of endometrial regeneration in patients with fertility challenges.

Disclaimer: The research mentioned regarding “Vaginal Microbiome Transplants” and the use of Vandazole to “clear the field” for donor bacteria is currently an active and promising area of clinical investigation. While this represents a significant frontier in gynecological research for recurrent BV, it is not yet part of standardized clinical practice or validated for professional medical decision-making in 2026.

Patient Management and Practical Recommendations

Pre-treatment Tests

  • Vaginal pH Test: To confirm a pH greater than 4.5.
  • Wet Mount/Microscopy: To identify clue cells and rule out other infections like Yeast or Trichomoniasis.
  • Whiff Test: To check for the characteristic amine odor.

Precautions During Treatment

  • Alcohol Avoidance: Do not consume alcohol during treatment and for at least 48 to 72 hours after the final dose to avoid severe illness.
  • Sexual Activity: It is recommended to avoid vaginal intercourse during the 5-day treatment course to allow the vaginal tissues to heal and prevent further irritation.
  • Menstruation: The treatment can be continued during a menstrual period, but the use of tampons should be avoided as they may absorb the medication.

“Do’s and Don’ts”

  • DO complete the full 5-day course, even if symptoms disappear after day two.
  • DO use the medication at bedtime to prevent the gel from leaking out while walking.
  • DON’T use douches or other vaginal products while using Vandazole.
  • DON’T consume “hidden” alcohol in mouthwashes or cough syrups.

Legal Disclaimer

This guide is provided for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this guide.

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91